Study on the Efficacy and Safety of Low-dose CTX as Maintenance Therapy for MM Unsuitable for Transplantation

Clinical trial NCT06324266 · UNKNOWN

Trial details

NCT number: NCT06324266
Sponsor: Jinling Hospital, China
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Newly Diagnosed Multiple Myeloma

Start date: 2023-04-16
Primary completion: 2025-12-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.